Kiromic Biopharma Probability of Future Stock Price Finishing Under 3.43

KRBPDelisted Stock  USD 2.68  0.07  2.55%   
Kiromic Biopharma's future price is the expected price of Kiromic Biopharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kiromic Biopharma performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
  
Please specify Kiromic Biopharma's target price for which you would like Kiromic Biopharma odds to be computed.

Kiromic Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kiromic Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kiromic Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Kiromic Biopharma is not yet fully synchronised with the market data
Kiromic Biopharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (34.73 M) with profit before overhead, payroll, taxes, and interest of 0.
Kiromic Biopharma currently holds about 6.51 M in cash with (23.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Roughly 68.0% of the company shares are owned by institutional investors

Kiromic Biopharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kiromic Stock often depends not only on the future outlook of the current and potential Kiromic Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kiromic Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding544.5 K
Cash And Short Term Investments645.2 K

Kiromic Biopharma Technical Analysis

Kiromic Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Kiromic Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kiromic Biopharma. In general, you should focus on analyzing Kiromic Stock price patterns and their correlations with different microeconomic environments and drivers.

Kiromic Biopharma Predictive Forecast Models

Kiromic Biopharma's time-series forecasting models is one of many Kiromic Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Kiromic Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Kiromic Biopharma

Checking the ongoing alerts about Kiromic Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Kiromic Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Kiromic Biopharma is not yet fully synchronised with the market data
Kiromic Biopharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (34.73 M) with profit before overhead, payroll, taxes, and interest of 0.
Kiromic Biopharma currently holds about 6.51 M in cash with (23.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Roughly 68.0% of the company shares are owned by institutional investors
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Kiromic Stock

If you are still planning to invest in Kiromic Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic Biopharma's history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios